Most conversations about pre-IPO secondary sales assume a simple fact pattern: one employee, one grant, one question about whether to sell — real employee equity situations are rarely that clean. Reality is messier. If you have been at a company for three or more years, you almost certainly have multiple equity grants — an original hire package plus one or more refresh grants layered on top, likely with different vesting schedules, different strike prices, and in some cases different security types.
Before you initiate a secondary sale, you need to understand which shares you are actually selling, because the answer determines your tax position, your eligibility for QSBS treatment, your remaining unvested upside, and in some cases whether company consent is even available for that specific tranche.
Why refresh grants complicate the picture
A refresh grant is an equity award issued after your initial hire to retain you. It is typically a new option or RSU grant with a fresh vesting cliff — often a one-year cliff followed by monthly vesting over three years. The strike price of a refresh option grant reflects the 409A valuation at the time of issuance, which for companies that have grown significantly since your hire date may be substantially higher than your original grant's strike.
This has two practical consequences for a secondary sale. First, the net proceeds per share are different across grants. If your original ISOs (incentive stock options) carry a $2.00 strike and your refresh ISOs carry an $18.00 strike, selling shares from the refresh tranche — assuming you have exercised them — leaves you with lower net proceeds per share at the same secondary price. Second, the tax treatment may differ. Original ISOs that were exercised early (via an 83(b) election) and have been held long enough may qualify for preferential long-term capital gains rates or even QSBS treatment under Section 1202. Refresh grant shares exercised more recently may not.
Mapping your grant stack before you approach the secondary market
Pull your equity plan statements — typically available through your company's equity platform (Carta, Pulley, Shareworks, etc.) — and build a simple table before you have any conversation with a marketplace or broker.
Once you have this table, two things become visible. First, you can rank your tranches by net-proceeds efficiency — which lot delivers the most after-tax dollars per share at a given secondary price. Second, you can identify whether any tranche is inside a holding period that, if crossed, would change the tax outcome materially.
The holding period question for each tranche
For shares that may qualify under QSBS rules (Section 1202 of the tax code), the qualifying holding period is five years from the date of acquisition of the stock itself — meaning the exercise date for options, not the grant date. If your original ISO exercises are approaching or past the five-year mark, selling from a refresh tranche that was exercised eighteen months ago forfeits that potential exclusion. Consult a tax adviser to confirm your eligibility before selling any lot near a qualifying threshold.
For standard long-term capital gains treatment, the holding period is one year from exercise. If you exercised refresh grant options eight months ago, waiting four more months before selling those specific shares changes the tax rate on that tranche from ordinary income rates to long-term capital gains rates. The difference can be 15 to 20 percentage points depending on your total income that year.
None of this requires you to wait on your original, long-held shares. You can sell from the older, tax-advantaged tranche now while leaving the newer tranche alone until the holding period matures. This is the core insight that multi-grant holders miss: the decision about when to sell is not binary across your entire position.
Unvested refresh grants and the termination risk calculus
There is a scenario that makes the multi-grant picture more urgent, not less: voluntary or involuntary separation from the company. If you leave, unvested shares are forfeited. For employees who are considering both a secondary sale and a job change, the sequence matters.
A secondary sale of vested shares before separation locks in the value of what you have already earned. Unvested shares from a refresh grant cannot be included — they do not exist yet as transferable property. But the vested portion of your original grant, if it is substantial, may be worth transacting before any employment uncertainty changes the picture.
Post-termination exercise windows also interact here. Many option plans give terminated employees 90 days to exercise vested options before they expire. If you are close to separation, the cost of exercising before you leave — and the AMT exposure that exercise may trigger — needs to be weighed against the value of those options. That is a tax and financial planning question, but the secondary market timing question is adjacent: if you want to sell exercised shares, you generally need to have exercised and held them, which means exercise decisions upstream affect secondary timing downstream.
How transfer consent interacts with multiple tranches
Companies issue transfer consent on a transaction-by-transaction basis, not on a blanket basis across your entire equity position. When you submit a transfer request, the company (and its legal counsel) reviews which specific shares you are selling — identified by certificate number or ledger entry — and whether those shares are subject to ROFR, a right of co-sale, a lockup, or any other contractual restriction.
If you have multiple grants, it is theoretically possible that consent is granted for one tranche and denied or delayed for another. This is more common than sellers expect, particularly when refresh grants were issued under a more recent equity plan with updated transfer restrictions. Knowing which tranche you want to sell before you approach the company for consent avoids a negotiation that starts from the wrong place.
A practical checklist before you list
- Pull your equity plan summary and identify every grant by date, type, strike price, and vested quantity.
- For each vested lot, calculate the estimated net proceeds after strike price and confirm which capital gains rate applies based on your exercise date.
- Flag any lots that are within 12 months of a long-term capital gains threshold or within 5 years of a potential QSBS qualifying date — and discuss with a tax adviser before deciding which lot to sell.
- Review the transfer restriction language specific to each grant agreement, not just the company's general transfer policy document.
- Decide in advance which tax lot you are designating for the sale, and document that decision in writing before you execute.
Secondary markets move on the pace of buyer demand, company consent timelines, and ROFR windows — not on your tax planning calendar. The fastest way to protect yourself is to complete this analysis before you express an interest to sell, not while a transaction is already in motion.
When you are ready to explore your options, the seller flow on Limen Markets walks through the key details — including which security type and which tranche you intend to offer — before any indication goes to buyers. Review the Seller Playbook for more on how the process works from first contact through settlement.